Re: Modjtahedi et al.: Guidelines for the diagnosis, management, and study of autoimmune retinopathy from the American Academy of Ophthalmology’s Task Force (Ophthalmol Retina. 2025;9:1005–1016)
Elsevier ·
The publisher did not provide an abstract — full text is available via the link below.
Re: Modjtahedi et al.: Guidelines for the diagnosis, management, and study of autoimmune retinopathy from the American Academy of Ophthalmology’s Task Force (Ophthalmol Retina. 2025;9:1005–1016). // Ophthalmology Retina. – URL: https://www.sciencedirect.com/science/article/pii/S2468653026004215?dgcid=rss_sd_all
Re: Modjtahedi et al.: Guidelines for the diagnosis, management, and study of autoimmune retinopathy from the American Academy of Ophthalmology’s Task Force (Ophthalmol Retina. 2025;9:1005–1016). Ophthalmology Retina. https://www.sciencedirect.com/science/article/pii/S2468653026004215?dgcid=rss_sd_all
“Re: Modjtahedi et al.: Guidelines for the diagnosis, management, and study of autoimmune retinopathy from the American Academy of Ophthalmology’s Task Force (Ophthalmol Retina. 2025;9:1005–1016).” Ophthalmology Retina.
@article{article60993,
title = {Re: Modjtahedi et al.: Guidelines for the diagnosis, management, and study of autoimmune retinopathy from the American Academy of Ophthalmology’s Task Force (Ophthalmol Retina. 2025;9:1005–1016)},
journal = {Ophthalmology Retina},
url = {https://www.sciencedirect.com/science/article/pii/S2468653026004215?dgcid=rss_sd_all}
}